[1]
A. Yildiz and Y. Kaya, “Investigation of the Factors Effecting Inhibition by Changing Substitute Groups of 6LU7 Protein-Favipiravir Molecules Used in the Treatment of Covid 19”, JERAS, vol. 9, no. 2, pp. 1496-1502, Dec. 2020.